Australian Clinical Labs Limited (ASX:ACL)
Australia
· Delayed Price · Currency is AUD 2.770
-0.010 (-0.36%)
Jun 6, 2025, 4:10 PM AEST
Australian Clinical Labs Market Cap
Australian Clinical Labs has a market cap or net worth of 538.34 million as of June 6, 2025. Its market cap has increased by 21.49% in one year.
Market Cap
538.34M
Enterprise Value
832.48M
Revenue
728.27M
Ranking
n/a
PE Ratio
18.04
Stock Price
2.77
Market Cap Chart
Since May 14, 2021, Australian Clinical Labs's market cap has decreased from 690.27M to 538.34M, a decrease of -22.01%. That is a compound annual growth rate of -5.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 538.34M | -21.35% |
| Dec 31, 2024 | 684.50M | 18.13% |
| Dec 29, 2023 | 579.45M | -3.17% |
| Dec 30, 2022 | 598.41M | -52.18% |
| Dec 31, 2021 | 1.25B | 81.29% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 117.14B |
| Pro Medicus | 28.83B |
| Cochlear | 17.56B |
| Sonic Healthcare | 12.67B |
| Ramsay Health Care | 8.65B |
| Telix Pharmaceuticals | 8.64B |
| Ansell | 4.51B |
| Regis Healthcare | 2.27B |